By Scientia Professor John Martin Kaldor

Journal articles

Law MG; Dore GJ; Bath N; Thompson S; Crofts N; Dolan K; Giles W; Gow P; Kaldor J; Loveday S; Powell E; Spencer J; Wodak A, 2003, 'Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001', International Journal of Epidemiology, 32, pp. 717 - 724, http://dx.doi.org/10.1093/ije/dyg101

Murray JM; Law MG; Gao Z; Kaldor JM, 2003, 'The impact of behavioral changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users', International Journal of Epidemiology, 32, pp. 708 - 714, http://dx.doi.org/10.1093/ije/dyg102

Miller J; Carr A; Emery S; Law M; Mallal S; Baker D; Smith D; Kaldor J; Cooper DA, 2003, 'HIV lipodystrophy: Prevalence, severity and correlates of risk in Australia', HIV Medicine, 4, pp. 293 - 301, http://dx.doi.org/10.1046/j.1468-1293.2003.00159.x

Freeman AJ; Law MG; Kaldor JM; Dore GJ, 2003, 'Predicting progression to cirrhosis in chronic hepatitis C virus infection', Journal of Viral Hepatitis, 10, pp. 285 - 293, http://dx.doi.org/10.1046/j.1365-2893.2003.00436.x

Sullivan EA; Abel M; Tabrizi S; Garland SM; Grice A; Poumerol G; Taleo H; Chen S; Kaun K; O'Leary M; Kaldor J, 2003, 'Prevalence of sexually transmitted infections among antenatal women in Vanuatu, 1999-2000', Sexually Transmitted Diseases, 30, pp. 362 - 366, http://dx.doi.org/10.1097/00007435-200304000-00017

Dore GJ; Law M; MacDonald M; Kaldor JM, 2003, 'Epidemiology of hepatitis C virus infection in Australia', Journal of Clinical Virology, 26, pp. 171 - 184, http://dx.doi.org/10.1016/S1386-6532(02)00116-6

Dore GJ; MacDonald M; Law MG; Kaldor JM, 2003, 'Epidemiology of hepatitis C virus infection in Australia.', Australian Family Physician, 32, pp. 796 - 798

Hiransuthikul N; Hanvanich M; Dore GJ; Mokkhawes T; Li Y; Perriens J; Kaldor JM, 2003, 'Factors associated with tuberculin skin test reactivity among HIV-infected people in Bangkok', Southeast Asian Journal of Tropical Medicine and Public Health, 34, pp. 804 - 809

Dore GJ; Freeman AJ; Law M; Kaldor JM, 2003, 'Natural history models for hepatitis C-related liver disease: Different disease progression parameters for different settings', Antiviral Therapy, 8, pp. 365 - 372, http://dx.doi.org/10.1177/135965350300800502

Micallef JM; Jauncey M; Amin J; Rawlinson W; Gilmour S; van Beek I; Kaldor JM; White PA; Dore GJ, 2003, '229 Hepatitis C virus reinfection within a cohort of injecting drug users', Hepatology, 38, pp. 266, http://dx.doi.org/10.1016/s0270-9139(03)80272-0

Blumer C; Roche P; Spencer J; Lin M; Milton A; Bunn C; Gidding HF; Kaldor JM; Kirk M; Hall R; Della-Porta T; Leader R; Wright P, 2003, 'Australia's notifiable diseases status, 2001: annual report of the National Notifiable Diseases Surveillance System', Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, 27, pp. 1 - 78

Butler TG; Levy MH; Dolan K; Kaldor JM, 2003, 'Drug use and its correlates in an Australian prison population', Addiction Research and Theory, 11, pp. 89 - 101

MacDonald MA; Law MG; Kaldor JM; Hales J; Dore GJ, 2003, 'Effectiveness of needle and syringe programmes for preventing HIV transmission', International Journal of Drug Policy, 14, pp. 353 - 357

Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench R, 2003, 'Effector HIV-specific cytotoxic T lymphocyte activity in HIV non-progressors correlates with viral replication and progression', Journal of Medical Virology, 71, pp. 483 - 491

O Sullivan BG; Levy MH; Dolan K; Post JJ; Barton SG; Dwyer D; Kaldor JM; Grulich AE, 2003, 'Hepatitis C transmission and HIV post-exposure prophylaxis after needle-and syringe-sharing in Australian prisons', Medical Journal of Australia, 178, pp. 546 - 549

Kaldor JM; McDonald AM, 2003, 'HIV/AIDS surveillance systems in Australia', Journal of Acquired Immune Deficiency Syndrome, 32, pp. 18 - 23

French MA; Herring BL; Kaldor JM; Sayer DC; Furner V; Chaneet CC; Dwyer DE, 2003, 'Intrafamilial transmission of HIV 1 infection from individuals with unrecognised HIV 1 Infection', AIDS, 17, pp. 1977 - 1981

McDonald AM; Li Y; Dore GJ; Ree H; Kaldor JM, 2003, 'Late HIV presentation among AIDS cases in Australia, 1992-2001', Australian and New Zealand Journal of Public Health, 27, pp. 608 - 613

Dore GJ; McDonald AM; Li Y; Kaldor JM; Brew BJ, 2003, 'Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy', AIDS, 17, pp. 1539 - 1545

Kaldor J, 2003, 'Obituary-Margaret MacDonald 1956–2003', International Journal of Drug Policy, 14, pp. 349 - 349, http://dx.doi.org/10.1016/j.drugpo.2003.10.002

Spencer J; Tibbits D; Tippet C; Mead C; Kaldor JM; Dore GJ, 2003, 'Review of antenatal testing policies and pratice for HIV and hepatitis C infection', Australian and New Zealand Journal of Public Health, 27, pp. 614 - 619

Kippax SC; Slavin SF; Ellard JM; Hendry O; Richters J; Grulich AE; Kaldor JM, 2003, 'Seroconversion in context', AIDS Care - Psychological and Socio - Medical Aspects of AIDS/HIV, 15, pp. 839 - 852

Kimber J; MacDonald MA; Van Beek IA; Kaldor JM; Weatherburn D; Lapsley HM; Mattick RP, 2003, 'The Sydney Medically Injecting Centre : Client Characteristics and Predictors of Frequent Attendance Druing the First 12 Months of Operation', Journal of Drug Issues, 33, pp. 639 - 648

Collins S; Boyd A; Lee JS; Lewis V; Fletcher A; McLean CA; Law M; Kaldor J; Smith MJ; Masters CL, 2002, 'Creutzfeldt-Jakob disease in Australia 1970-1999', Neurology, 59, pp. 1365 - 1371, http://dx.doi.org/10.1212/01.WNL.0000031793.11602.8C

Babiker A; Darbyshire J; Pezzotti P; Porter K; Rezza G; Walker AS; Beral V; Coutinho R; Del Amo J; Gill N; Lee C; Meyer L; Tyrer F; Dabis F; Thiebaut R; Lawson-Aye S; Boufassa F; Hamouda O; Fischer K; Touloumi G; Hatzakis A; Karafoulidou A; Katsarou O; Brettle R; del Romero J; Prins M; van Benthem B; Kirk O; Pedersen C; Hernández Aguado I; Pérez-Hoyos S; Eskild A; Bruun JN; Sannes M; Sabin C; Johnson AM; Phillips AN; Francioli P; Vanhems P; Egger M; Riekenbach M; Cooper D; Kaldor J; Ashton L; Vissard J; Muga R; Day NE; De Angelis D, 2002, 'Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks', International Journal of Epidemiology, 31, pp. 951 - 958, http://dx.doi.org/10.1093/ije/31.5.951

Jin FY; Prestage G; Law MG; Kippax S; Van de Ven P; Rawsthorne P; Kaldor JM; Grulich AE, 2002, 'Predictors of recent HIV testing in homosexual men in Australia', HIV Medicine, 3, pp. 271 - 276, http://dx.doi.org/10.1046/j.1468-1293.2002.00121.x

Dore GJ; Freeman AJ; Kaldor JM; Post JJ; Harvey CE; Ffrench RA; Lloyd AR; Mehta SH; Cox AL; Strathdee SA; Vlahov D; Thomas DL, 2002, 'Immunity against hepatitis C virus infection [2] (multiple letters)', Lancet, 360, pp. 1019 - 1020, http://dx.doi.org/10.1016/s0140-6736(02)11102-0

Ashton LJ; Stewart GJ; Biti R; Law M; Cooper DA; Kaldor JM, 2002, 'Heterozygosity for CCR5-Δ32 but not CCR2b-641 protects against certain intracellular pathogens', HIV Medicine, 3, pp. 91 - 96, http://dx.doi.org/10.1046/j.1468-1293.2002.00106.x

Grulich AE; Li Y; McDonald A; Correll PKL; Law MG; Kaldor JM, 2002, 'Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis', AIDS, 16, pp. 1155 - 1161, http://dx.doi.org/10.1097/00002030-200205240-00009

Li Y; Law M; McDonald A; Correll P; Kaldor JM; Grulich AE, 2002, 'Estimation of risk of cancers before occurrence of acquired immunodeficiency syndrome in persons infected with human immunodeficiency virus', American Journal of Epidemiology, 155, pp. 153 - 158, http://dx.doi.org/10.1093/aje/155.2.153

Lin M; Roche P; Spencer J; Milton A; Wright P; Witteveen D; Leader R; Merianos A; Bunn C; Gidding H; Kaldor J; Kirk M; Hall R; Della-Porta T, 2002, 'Australia's notifiable diseases status, 2000. Annual report of the National Notifiable Diseases Surveillance System.', Communicable Diseases Intelligence, 26, pp. 118 - 203

Dore GJ; Freeman AJ; Law M; Kaldor JM, 2002, 'Is severe liver disease a common outcome for people with chronic hepatitis C?', Journal of Gastroenterology and Hepatology Australia, 17, pp. 423 - 430, http://dx.doi.org/10.1046/j.1440-1746.2002.02730.x

Dore GJ; Freeman A; Kaldor JM, 2002, '. Immunity against hepatitis C virus infection', Lancet, 360, pp. 1019 - 1020

Miller J; Brown DA; Amin J; Kent-Hughes J; Law MG; Cooper DA; Carr AD, 2002, 'A randomised, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia', AIDS, 16, pp. 2195 - 2200

Kaldor JM, 2002, 'Biomedical Responses to the AIDS epidemic', Australasian Science, pp. 18 - 20

Collins SP; Boyd A; Fletcher A; Kaldor JM; Hill A; Farish S; Mclean C; Ansari Z; Smith MJ; Masters CL, 2002, 'Creutzfeldt-Jakob disease cluster in an Australian rural city', Annals of Neurology, 52, pp. 115 - 118

Grulich AE; Kaldor JM, 2002, 'Evidence of success in HIV prevention in Africa', Lancet, 360, pp. 3 - 4

Danta M; Dore GJ; Hennessy L; Li Y; Vickers CR; Harley H; Ngu M; Reed W; Desmond PV; Sievert W; Farrell G; Kaldor JM; Batey RG, 2002, 'Factors associated with severity of hepatic fibrosis in people with chronic hepatitis C infection', Medical Journal of Australia, 177, pp. 240 - 245

Dore GJ; Li Y; McDonald AM; Ree H; Kaldor JM, 2002, 'Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 29, pp. 388 - 395

Spencer J; Dore GJ; Robotin M; Correll PK; Kaldor JM, 2002, 'Outcomes from the first two years of the Australian Hepatitis surveillance strategy', Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, 26, pp. 14 - 22

Butler T; Donovan BJ; Levy MH; Kaldor JM; Butler , 2002, 'Sex behind the prison walls', Australian and New Zealand Journal of Public Health, 26, pp. 390 - 390

Law MG; Dore GJ; Kaldor JM, 2001, 'Projecting severe sequelae of injection-related hepatitis C virus epidemic in UK by SM Bird, DJ Goldberg and SJ Hutchinson', Journal of Epidemiology and Biostatistics, 6, pp. 279 - 281, http://dx.doi.org/10.1080/135952201317080689

Babiker A; Darbyshire J; Pezzotti P; Porter K; Rezza G; Walker S; Beral V; Coutinho R; Del Amo J; Gill N; Lee C; Meyer L; Tyrer F; Dabis F; Thiebaut R; Lawson-Ayayi S; Boufassa F; Hamouda O; Lorenzo JI; Touloumi G; Hatzakis A; Karafoulidou A; Katsarou O; Brettle R; Del Romero J; Prins M; Van Benthem B; Kirk O; Pedersen C; Hernández Aguado I; Pérez-Hoyos S; Eskild A; Bruun JN; Sannes M; Sabin C; Johnson AM; Phillips AN; Babiker A; Francioli P; Vanhems P; Egger M; Rickenbach M; Cooper D; Kaldor J; Vizzard J; Tusell JM; Ruiz I; Cayla JA; Garcia de Olalla P; Day NE; De Angelis D, 2001, 'Is the time from HIV seroconversion a determinant of the risk of AIDS after adjustment for updated CD4 cell counts?', Journal of Acquired Immune Deficiency Syndromes, 28, pp. 158 - 165, http://dx.doi.org/10.1097/00126334-200110010-00008

Correll PK; Law MG; Seed CR; Gust A; Buring M; Dax EM; Keller AJ; Kaldor JM, 2001, 'Variant Creutzfeldt-Jakob disease in Australian blood donors: Estimation of risk and the impact of deferral strategies', Vox Sanguinis, 81, pp. 6 - 11, http://dx.doi.org/10.1046/j.1423-0410.2001.00056.x

Grulich AE; Hendry O; Clark E; Kippax S; Kaldor JM, 2001, 'Circumcision and male-to-male sexual transmission of HIV', AIDS, 15, pp. 1188 - 1189, http://dx.doi.org/10.1097/00002030-200106150-00020

Grulich AE; Li Y; McDonald AM; Correll PK; Law MG; Kaldor JM, 2001, 'Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination antiretroviral therapy', AIDS, 15, pp. 629 - 633, http://dx.doi.org/10.1097/00002030-200103300-00013

Miller PJ; Law M; Torzillo PJ; Kaldor J, 2001, 'Incident sexually transmitted infections and their risk factors in an aboriginal community in Australia: A population based cohort study', Sexually Transmitted Infections, 77, pp. 21 - 25, http://dx.doi.org/10.1136/sti.77.1.21

Freeman AJ; Dore GJ; Law MG; Thorpe M; Von Overbeck J; Lloyd AR; Marinos G; Kaldor JM, 2001, 'Estimating progression to cirrhosis in chronic hepatitis C virus infection', Hepatology, 34, pp. 809 - 816, http://dx.doi.org/10.1053/jhep.2001.27831

Lister S; Sheppeard V; Morgan G; Corbett S; Kaldor J; Henry R, 2001, 'February asthma outbreaks in NSW: A case control study', Australian and New Zealand Journal of Public Health, 25, pp. 514 - 519, http://dx.doi.org/10.1111/j.1467-842X.2001.tb00315.x

Butler T; Donovan BJ; Fleming J; Levy MH; Kaldor JM; Butler , 2001, 'Childhood sexual abuse among Australian prisoners.', Venereology - the Interdisciplinary International Journal of Sexual Health, 14, pp. 109 - 115

Back to profile page